News by Topic

Click on a topic below to see the latest headline

Customize "My Headlines" by Topic

Choose the topics of most interest to you to follow under "My Headlines".

Subscribe

Sign up for newsletters, news feeds, social media and other news sources.

Resources for News Media

Are you a reporter working on a story? Here's where you find help from Duke.

Duke Officials Praise IOM Report on 'Omics' Research

Duke Officials Praise IOM Report on 'Omics' Research

print |

Durham, NC - Duke University officials praised an Institute of Medicine (IOM) report released Friday that offers recommendations for preserving research integrity in the translation of genomics and other "omics" research into clinical medicine.

The IOM, the health arm of the National Academy of Sciences, pursued the report at the request of both the National Cancer Institute and Duke to guide universities and other research facilities in overseeing increasingly complicated medical studies involving "omics," which typically  involve large data sets and complex algorithms.

The IOM summarized its findings in a press release and posted the full report online here.

In a statement Friday, Duke Medicine's leadership called the IOM report an "important contribution to the field of genomics and translational research," saying "the recommendations contained in the report provide a clear path forward that will guide researchers as they bring genomic research through the translational system to benefit patients."

Here is full Duke statement signed by Dr. Victor J. Dzau, chancellor for health affairs, Dr. Nancy Andrews, dean of the School of Medicine and Dr. Rob Califf, vice chancellor for clinical and translational research.

"We at Duke Medicine greatly appreciate the thoughtful and thorough work done by the IOM committee in creating this report.  It represents an important contribution to the field of genomics and translational research and the recommendations contained in the report provide a clear path forward that will guide researchers as they bring genomic research through the translational system to benefit patients. The impressive depth of the report will provide great value to the spectrum of participants in the research and development system, including regulatory agencies, basic and clinical research communities, and, ultimately, patients.  

"We welcome the opportunity to incorporate the recommendations from this report with our ongoing efforts to strengthen the rigor of our research enterprise. We have learned from our situation, and with the dedicated efforts of our faculty and administration we have begun to implement solutions under our Translational Medicine Quality Framework. This report will provide additional valuable approaches.

"'Omics' research is a critically important area of scientific investigation that holds great promise for improving patient care, and today's report is perhaps the most important contribution to date in providing analysis and guidance to ensure its rigor and reproducibility.

"Thanks to the committee members, and to the IOM, for undertaking this project."

© 2014 Office of News & Communications
615 Chapel Drive, Box 90563, Durham, NC 27708-0563
(919) 684-2823; After-hours phone (for reporters on deadline): (919) 812-6603